Observation of Clinical Treatment Efficacy in Severe Heart Failure of Geriatric Cardiology

Qi Yuan

Abstract

Objective: To explore the clinical treatment efficacy of severe heart failure in geriatric cardiology.Methods: A total of 122 cases of severe heart failure patients admitted to our hospital from January 2022 to December 2023 were selected as the research subjects. The patients were divided into two groups using digital random grouping method, with 61 cases in each group. The control group was treated with metoprolol, while the experimental group was treated with metoprolol combined with eplerenone hydrochlorothiazide. The occurrence rate of adverse reactions and treatment efficacy of clinical indicators were compared between the two groups.Results: There was no significant difference in the incidence of adverse reactions (P > 0.05); the clinical indicators of the experimental group were better than those of the control group, and the total effective rate of treatment was higher than that of the control group. The difference in comparison results was statistically significant (P < 0.05). Conclusion: For the treatment of severe heart failure in geriatric patients in cardiology,metoprolol combined with eplerenone hydrochlorothiazide can be used, which can significantly improve the clinical signs of patients, increase the total effective rate of treatment, and will not significantly increase the risk of adverse reactions. It is worth further promotion and application.

Keywords

Cardiology; Severe heart failure; Geriatric patients

Full Text

PDF

References

Copyright © 2024 Qi Yuan Publishing time:2024-02-27
This work is licensed under a Creative Commons Attribution 4.0 International License